Clinical information associated with bacterial culture proven Burkholderia pseudomallei among melioiodosis patients in Buriram province 10.55131/jphd/2023/210303
Article Sidebar
Main Article Content
Abstract
Indirect hemagglutination assay (IHA) is a general rapid diagnosis procedure in melioidosis patients combined with clinical information. The Burkholderia pseudomallei culture technique requires prolonged time before getting culture results. Related factors of bacterial culture proven melioidosis and the appropriate cut-off point for IHA are unfashionable and need to be updated. A cross-sectional study was conducted among melioidosis patients using data reported in the medical records. Univariable analysis was performed by Chi-square test and Student T-test as appropriate. Multivariable logistic regression was finally used to identify the contributing factors to bacterial culture proven cases. The results were shown as adjusted odds ratio (AdjOR) and 95%CI. Validity domains, sensitivity, specificity, predictive values, and likelihood ratios at each cut-off point for IHA were demonstrated. The results revealed that after adjustment for abdominal pain symptoms, diabetes mellitus (DM)(p-value < 0.001) and dyspnea symptoms (p-value = 0.025) were the associated factors of bacterial culture proven cases. The IHA titer > 1: 10240 provided the highest positive and negative predictive values, 30% and 69% respectively. Both positive and negative likelihood ratios of this cut-off point were also accounted for as 0.95 and 1.003, respectively. Health personnel should perform melioidosis diagnosis by the use of clinical information and an appropriate cut-off point for IHA, especially in diabetic patients who have dyspnea.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Shaharudin R, Ahmad N, Kamaluddin MA, Veloo Y. Detection of Burkholderia Pseudomallei from post-flood soil samples in Kelantan, Malaysia. Southeast Asian J Trop Med Public Health. 2016;47(5):952–6.
Bleny D. Melioidosis. In: David L.Heymann. Control of communicable diseases manual. 20th ed: American Public Health Association; 2015. p. 397 – 401.
Mohapatra PR, Mishra B. Burden of melioidosis in India and South Asia: Challenges and ways forward. Lancet Reg Heal - Southeast Asia. 2022;2:100004. doi: 10.1016/j.lansea. 2022.03.004
Birnie E, Virk HS, Savelkoel J, Spijker R, Dance PDAB, Limmathurotsakul D. Europe PMC Funders Group Global burden of melioidosis , 2015 : a systematic review and data synthesis. Lancet Infect Dis. 2020;19(8):892–902.
Selvam K, Ganapathy T, Najib MA, Khalid MF, Abdullah NA, Harun A, et al. Burden and Risk Factors of Melioidosis in Southeast Asia: A Scoping Review. Int J Environ Res Public Health. 2022;19(23):1–16. doi: 10.3390/ijerph192315475.
Hinjoy S, Hantrakun V, Kongyu S, Kaewrakmuk J, Wangrangsimakul T, Jitsuronk S, et al. Melioidosis in Thailand: Present and Future. Trop Med Infect Dis. 2018;3(2):38. doi: 10.3390/ tropicalmed3020038
Waiwarawooth J, Jutiworakul K, Joraka W. Epidemiology and clinical outcome of melioidosis at Chonburi Hospital, Thailand. J Infect Dis Antimicrob Agents. 2008;25(1):1–11.
Hemarajata P, Baghdadi JD, Hoffman R, Humphries RM. Burkholderia pseudomallei: Challenges for the Clinical Microbiology Laboratory. J Clin Microbiol. 2016;54(12):2866-73. doi: 10.1128/JCM.01636-16
American Society for Microbiology. Sentinel level clinical laboratory guidelines for suspected agents of bioterrorism and Glanders : Burkholderia mallei and Melioidosis : Burkholderia pseudomallei. American Society for Microbiology; 2016. p. 7–9.
Paksanont S, Sintiprungrat K, Yimthin T, Pumirat P, Peacock SJ, Chantratita N. Effect of temperature on Burkholderia pseudomallei growth, proteomic changes, motility and resistance to stress environments. Sci Rep. 2018;8(1):1–13. doi: 10.1038/ s41598-018-27356-7
Hoffmaster AR, AuCoin D, Baccam P, Baggett HC, Baird R, Bhengsri S, et al. Melioidosis diagnostic workshop, 2013. Emerg Infect Dis. 2015;21(2). doi: 10.3201/eid2102.141045
Wangroongsarb P, Kumsawat S, Petkanjanapong W, Kotprom W, Naigowit P, Kusum M. Selection of Burkholderia pseudomallei antigens for antibody detection by indirect hemaggutination method. Chula Med J. 2000;44(8):631-42.
Sirisinha S. Diagnostic value of serological tests for melioidosis in an endemic area. Asian Pacific J Allergy Immunol. 1991;9(1):1–3.
Teparrugkul P. Indirect Hemaggutination Test for the Diagnosis of Melioidosis in Ubon Ratchathani. J Infect Dis Antibicrob Agents. 1997; 14(1):17–9.
Leelarasamee A. Diagnostic Value of Indirect Hemaggutination Test in Melioidosis. J Infect Dis Antibicrob Agents. 1996;14(1):57–9.
Wongratanacheewin S, Wongratanacheewin Sermswan R, Anuntagool N, Sirisinha S. Retrospective study on the diagnostic value of IgG ELISA, dot immunoassay and indirect hemagglutination in septicemic melioidosis. Asian Pacific J Allergy Immunol. 2001;19(2):129–33.
Darasawang W. Contributing factors to Melioidosis fatality in Buriram province. J Med Heal Sci. 2023;30(1):28–42.
World Health Organization. ICD-10 Version: 2019 [Internet]. 2019 [cited 2022 Dec 20]. Available from: https:// icd.who.int/browse10/2019/en#/A24.1
White NJ. Melioidosis. Lancet. 2003;361:1715–22. doi: 10.1016/s0140-6736(03)13374-0
Currie BJ, Jacups SP, Cheng AC, Fisher DA, Anstey NM, Huffam SE, et al. Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia. Trop Med Int Health. 2004;9(11):1167-74. doi: 10.1111/j.1365-3156.2004. 01328.x.
Suputtamongkol Y, Chaowagul W, Chetchotisakd P, Lertpatanasuwun N, Intaranongpai S, Ruchutrakool T, et al. Risk factors for melioidosis and bacteremic melioidosis. Clin Infect Dis. 1999;29(2):408-13. doi: 10.1086/ 520223.
Currie BJ, Ward L, Cheng AC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLOS Negl Trop Dis. 2010;4(11):e900. doi: 10.1371/journal.pntd.0000900.
Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N, Wongsuvan G, Chaisuksant S, Chetchotisakd P, et al. Increasing incidence of human melioidosis in Northeast Thailand. Am J Trop Med Hyg. 2010;82(6):1113-7. doi: 10.4269/ajtmh.2010.10-0038
Hassan MR, Pani SP, Peng NP, Voralu K, Vijayalakshmi N, Mehanderkar R, et al. Incidence, risk factors and clinical epidemiology of melioidosis: a complex socio-ecological emerging infectious disease in the Alor Setar region of Kedah, Malaysia. BMC Infect Dis. 2010;10:302. doi: 10.1186/1471-2334-10-302.
Chierakul W, Wuthiekanun V, Chaowagul W, Amornchai P, Cheng AC, White NJ, et al. Short report: disease severity and outcome of melioidosis in HIV coinfected individuals. Am J Trop Med Hyg. 2005; 73(6):1165-6.
Berliner D, Schneider N, Welte T, Bauersachs J. The differential diagnosis of dyspnoea. Dtsch Arztebl Int. 2016;113(49):834–44.
Sunjaya AP, Homaira N, Corcoran K, Martin A, Berend N, Jenkins C. Assessment and diagnosis of chronic dyspnoea: a literature review. NPJ Prim Care Respir Med. 2022;32(1):10. doi: 10.1038/s41533-022-00271-1
O'Brien M, Freeman K, Lum G, Cheng AC, Jacups SP, Currie BJ. Further evaluation of a rapid diagnostic test for melioidosis in an area of endemicity. J Clin Microbiol. 2004;42(5):2239-40. doi: 10.1128/JCM.42.5.2239-2240. 2004
Cheng AC, O'Brien M, Freeman K, Lum G, Currie BJ. Indirect hemagglutination assay in patients with melioidosis in northern Australia. Am J Trop Med Hyg. 2006;74(2):330-4.
Maze MJ, Elrod MG, Biggs HM, Bonnewell J, Carugati M, Hoffmaster AR, et al. Investigation of Melioidosis Using Blood Culture and Indirect Hemagglutination Assay Serology among Patients with Fever, Northern Tanzania. Am J Trop Med Hyg. 2020;103(6):2510-4. doi: 10.4269/ ajtmh.20-0160.
Trevethan R. Sensitivity, Specificity, and Predictive Values: Foundations, Pliabilities, and Pitfalls in Research and Practice. Front Public Health. 2017;5:307. doi: 10.3389/fpubh. 2017.00307
McGee S. Simplifying likelihood ratios. J Gen Intern Med. 2002; 17(8): 646-9. doi: 10.1046/j.1525-1497. 2002. 10750.x
Wuthiekanun V, Chierakul W, Langa S, Chaowagul W, Panpitpat C, Saipan P, et al. Short report: Development of antibodies to Burkholderia Pseudomallei during childhood in melioidosis-endemic Northeast Thailand. Am J Trop Med Hyg. 2006; 74(6):1074–5.
Chaichana P, Jenjaroen K, Amornchai P, Chumseng S, Langla S, Rongkard P, et al. Antibodies in melioidosis: The role of the indirect hemagglutination assay in evaluating patients and exposed populations. Am J Trop Med Hyg. 2018;99(6):1378–85.
Charoenwong P, Lumbiganon P, Puapermpoonsiri S. The prevalence of the indirect hemagglutination test for melioidosis in children in an endemic area. Southeast Asian J Trop Med Public Health. 1992;23(4):698-701.
Norazah A, Rohani MY, Chang PT, Kamel AG. Indirect hemagglutination antibodies against Burkholderia pseudomallei in normal blood donors and suspected cases of melioidosis in Malaysia. Southeast Asian J Trop Med Public Health. 1996;27(2):263-6.
Tiyawisutsri R, Peacock SJ, Langa S, Limmathurotsakul D, Cheng AC, Chierakul W, et al. Antibodies from patients with melioidosis recognize Burkholderia mallei but not Burkholderia thailandensis antigens in the indirect hemagglutination assay. J Clin Microbiol. 2005;43(9):4872-4. doi: 10.1128/JCM.43.9.4872-4874. 2005
Hantrakun V, Thaipadungpanit J, Rongkard P, Srilohasin P, Amornchai P, Langla S, et al. Presence of B. thailandensis and B. thailandensis expressing B. pseudomallei-like capsular polysaccharide in Thailand, and their associations with serological response to B. pseudomallei. PLOS Negl Trop Dis. 2018;12(1):e0006193. doi: 10.1371/journal.pntd.0006193